Mark Christianson, Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 11,707 shares at $1.40 ($16K) on 2023-12-21, disclosed to the SEC on 2023-12-26.
Open-market sale of $16k NMTC by Business Development Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 9,907 | $14K | 84.6% |
| 2 | $1.40 | 1,800 | $3K | 15.4% |
| Total | $1.40 avg | 11,707 | $16K | 100% |
| Filing → |
| NMTC | SELL | 2026-03-16 | $734 | — | Filing → |
| NMTC | SELL | 2026-03-12 | $11K | — | Filing → |
| NMTC | SELL | 2025-09-09 | $22K | — | Filing → |